Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrazones | 1 | 2024 | 14 | 0.840 |
Why?
|
| Pyridazines | 1 | 2024 | 49 | 0.820 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 137 | 0.770 |
Why?
|
| Cardiotonic Agents | 1 | 2024 | 138 | 0.760 |
Why?
|
| Fibroblasts | 2 | 2024 | 849 | 0.640 |
Why?
|
| Oxidative Stress | 1 | 2024 | 791 | 0.600 |
Why?
|
| Myocardium | 1 | 2024 | 852 | 0.590 |
Why?
|
| Immunoglobulin E | 7 | 2003 | 215 | 0.450 |
Why?
|
| Allergens | 7 | 2003 | 344 | 0.390 |
Why?
|
| Signal Transduction | 2 | 2024 | 4686 | 0.360 |
Why?
|
| Plant Proteins | 5 | 2003 | 86 | 0.290 |
Why?
|
| Hypersensitivity | 3 | 2003 | 227 | 0.220 |
Why?
|
| Heart Failure, Diastolic | 1 | 2024 | 10 | 0.210 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 33 | 0.210 |
Why?
|
| Diastole | 1 | 2024 | 181 | 0.200 |
Why?
|
| Skin Tests | 3 | 2003 | 101 | 0.200 |
Why?
|
| Transcriptional Activation | 1 | 2024 | 419 | 0.190 |
Why?
|
| Fibrosis | 1 | 2024 | 429 | 0.180 |
Why?
|
| Cell Survival | 1 | 2024 | 826 | 0.180 |
Why?
|
| Receptors, Progesterone | 2 | 2005 | 677 | 0.170 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2024 | 362 | 0.170 |
Why?
|
| Antigens, Dermatophagoides | 3 | 2003 | 14 | 0.140 |
Why?
|
| Rats | 1 | 2024 | 3370 | 0.140 |
Why?
|
| Apoptosis | 1 | 2024 | 1827 | 0.130 |
Why?
|
| Antigen-Antibody Reactions | 2 | 2002 | 19 | 0.110 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2004 | 20 | 0.110 |
Why?
|
| Antigens, Plant | 5 | 2003 | 35 | 0.110 |
Why?
|
| Serine | 1 | 2004 | 161 | 0.100 |
Why?
|
| Immunoglobulin Isotypes | 2 | 2002 | 14 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 300 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 1363 | 0.100 |
Why?
|
| Immunoglobulin G | 3 | 2002 | 786 | 0.100 |
Why?
|
| Glycoproteins | 2 | 2002 | 346 | 0.090 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 274 | 0.090 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1999 | 49 | 0.070 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1999 | 32 | 0.070 |
Why?
|
| Mice | 2 | 2024 | 18301 | 0.070 |
Why?
|
| Asthma | 2 | 2003 | 922 | 0.070 |
Why?
|
| Immunotherapy | 2 | 2000 | 768 | 0.060 |
Why?
|
| Antibody Affinity | 3 | 2002 | 37 | 0.060 |
Why?
|
| Animals | 3 | 2024 | 33912 | 0.060 |
Why?
|
| Antibody Specificity | 3 | 2002 | 164 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2005 | 2602 | 0.060 |
Why?
|
| Progestins | 2 | 2005 | 39 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 1722 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 2002 | 140 | 0.050 |
Why?
|
| Humans | 10 | 2024 | 131163 | 0.050 |
Why?
|
| Asteraceae | 2 | 2000 | 5 | 0.040 |
Why?
|
| Pollen | 2 | 2000 | 39 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 3748 | 0.030 |
Why?
|
| Mitogens | 1 | 2004 | 30 | 0.030 |
Why?
|
| Cyclin E | 1 | 2004 | 30 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 88 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2005 | 106 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 189 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 57 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2005 | 292 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 107 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2004 | 53 | 0.030 |
Why?
|
| Adult | 5 | 2003 | 31282 | 0.030 |
Why?
|
| Alanine | 1 | 2004 | 160 | 0.030 |
Why?
|
| Mites | 1 | 2003 | 7 | 0.030 |
Why?
|
| Ambrosia | 1 | 2003 | 14 | 0.030 |
Why?
|
| Arthropod Proteins | 1 | 2003 | 13 | 0.030 |
Why?
|
| Adolescent | 4 | 2003 | 20987 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2004 | 423 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2004 | 576 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 405 | 0.020 |
Why?
|
| Ligands | 1 | 2004 | 481 | 0.020 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 110 | 0.020 |
Why?
|
| Patch Tests | 1 | 2003 | 7 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2004 | 686 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2003 | 178 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2003 | 76 | 0.020 |
Why?
|
| RNA Interference | 1 | 2004 | 491 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 403 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2005 | 765 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2004 | 645 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2004 | 1013 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2002 | 32 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2005 | 556 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2005 | 594 | 0.020 |
Why?
|
| Dermatitis, Atopic | 1 | 2003 | 56 | 0.020 |
Why?
|
| Differential Threshold | 1 | 2002 | 7 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2003 | 6797 | 0.020 |
Why?
|
| Middle Aged | 4 | 2003 | 28601 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2003 | 318 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2002 | 44 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 484 | 0.020 |
Why?
|
| Age Distribution | 1 | 2003 | 422 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 148 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2004 | 767 | 0.020 |
Why?
|
| Child | 4 | 2003 | 26341 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2004 | 1571 | 0.020 |
Why?
|
| Immunodominant Epitopes | 1 | 2000 | 45 | 0.020 |
Why?
|
| Cell Line | 1 | 2005 | 2552 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 710 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 1371 | 0.020 |
Why?
|
| Aged | 3 | 2003 | 21025 | 0.020 |
Why?
|
| Family | 1 | 2003 | 589 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 1999 | 33 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2004 | 2885 | 0.020 |
Why?
|
| Male | 5 | 2003 | 64957 | 0.020 |
Why?
|
| Immunoassay | 1 | 1999 | 126 | 0.020 |
Why?
|
| Rhinitis | 1 | 1999 | 43 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1999 | 158 | 0.020 |
Why?
|
| Female | 5 | 2003 | 70963 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2005 | 2465 | 0.020 |
Why?
|
| Age Factors | 1 | 2003 | 2825 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 2395 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 3464 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 3360 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 3061 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2003 | 5063 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2003 | 3711 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 2323 | 0.010 |
Why?
|